Trial Profile
Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms HM10660A
- Sponsors Hanmi Pharmaceutical
- 19 Feb 2014 New trial record